| The 2019 American College of Rheumatology/European league against rheumatism classification criteria for IgG4‐related disease ZS Wallace, RP Naden, S Chari, H Choi, E Della‐Torre, JF Dicaire, ... Arthritis & Rheumatology 72 (1), 7-19, 2020 | 875 | 2020 |
| Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors M Ripa, L Galli, A Poli, C Oltolini, V Spagnuolo, A Mastrangelo, C Muccini, ... Clinical Microbiology and Infection 27 (3), 451-457, 2021 | 367 | 2021 |
| Immunology of IgG4-related disease E Della-Torre, M Lanzillotta, C Doglioni Clinical & Experimental Immunology 181 (2), 191-206, 2015 | 279 | 2015 |
| Advances in the diagnosis and management of IgG4 related disease M Lanzillotta, G Mancuso, E Della-Torre Bmj 369, 2020 | 267 | 2020 |
| Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation: an open-label cohort study E Della-Torre, C Campochiaro, G Cavalli, G De Luca, A Napolitano, ... Annals of the rheumatic diseases 79 (10), 1277-1285, 2020 | 256 | 2020 |
| IgG4-related disease in Italy: clinical features and outcomes of a large cohort of patients C Campochiaro, GA Ramirez, EP Bozzolo, M Lanzillotta, A Berti, ... Scandinavian journal of rheumatology 45 (2), 135-145, 2016 | 163 | 2016 |
| An International multispecialty validation study of the IgG4‐related disease responder index ZS Wallace, A Khosroshahi, MD Carruthers, CA Perugino, H Choi, ... Arthritis care & research 70 (11), 1671-1678, 2018 | 140 | 2018 |
| B lymphocytes directly contribute to tissue fibrosis in patients with IgG4-related disease E Della-Torre, E Rigamonti, C Perugino, S Baghai-Sain, N Sun, N Kaneko, ... Journal of Allergy and Clinical Immunology 145 (3), 968-981. e14, 2020 | 112 | 2020 |
| A CD 8α− Subset of CD 4+ SLAMF 7+ Cytotoxic T Cells Is Expanded in Patients With IgG4‐Related Disease and Decreases Following Glucocorticoid Treatment E Della‐Torre, E Bozzalla‐Cassione, C Sciorati, E Ruggiero, M Lanzillotta, ... Arthritis & Rheumatology 70 (7), 1133-1143, 2018 | 96 | 2018 |
| Antineutrophil cytoplasmic antibody positivity in IgG4-related disease: a case report and review of the literature E Della-Torre, M Lanzillotta, C Campochiaro, E Bozzalla, E Bozzolo, ... Medicine 95 (34), e4633, 2016 | 82 | 2016 |
| Clinical phenotypes of IgG4-related disease reflect different prognostic outcomes M Lanzillotta, C Campochiaro, G Mancuso, GA Ramirez, G Capurso, ... Rheumatology 59 (9), 2435-2442, 2020 | 78 | 2020 |
| Long-term efficacy of maintenance therapy with Rituximab for IgG4-related disease C Campochiaro, E Della-Torre, M Lanzillotta, E Bozzolo, E Baldissera, ... European Journal of Internal Medicine 74, 92-98, 2020 | 72 | 2020 |
| Members of the ACR/EULAR IgG4-RD classification criteria working group. The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for … ZS Wallace, RP Naden, S Chari, HK Choi, E Della-Torre, JF Dicaire, ... Ann Rheum Dis 79 (1), 77-87, 2020 | 70 | 2020 |
| Quantitative measurement of 18F-FDG PET/CT uptake reflects the expansion of circulating plasmablasts in IgG4-related disease A Berti, E Della-Torre, F Gallivanone, C Canevari, R Milani, M Lanzillotta, ... Rheumatology 56 (12), 2084-2092, 2017 | 62 | 2017 |
| Increase of circulating memory B cells after glucocorticoid-induced remission identifies patients at risk of IgG4-related disease relapse M Lanzillotta, E Della-Torre, R Milani, E Bozzolo, E Bozzalla-Cassione, ... Arthritis research & therapy 20, 1-10, 2018 | 54 | 2018 |
| American College of Rheumatology/European League Against Rheumatism IgG4-Related Disease Classification Criteria Working Group ZS Wallace, RP Naden, S Chari, H Choi, E Della-Torre, JF Dicaire, ... The, 2019 | 47 | 2019 |
| Deconstructing IgG4-related disease involvement of midline structures: Comparison to common mimickers M Lanzillotta, C Campochiaro, M Trimarchi, G Arrigoni, S Gerevini, ... Modern Rheumatology 27 (4), 638-645, 2017 | 46 | 2017 |
| Effects of glucocorticoids on B-cell subpopulations in patients with IgG4-related disease M Lanzillotta, E Della-Torre, R Milani, E Bozzolo, E Bozzalla-Cassione, ... Clin Exp Rheumatol 37 (Suppl 118), S159-S166, 2019 | 42 | 2019 |
| Respiratory impairment predicts response to IL-1 and IL-6 blockade in COVID-19 patients with severe pneumonia and hyper-inflammation E Della-Torre, M Lanzillotta, C Campochiaro, G Cavalli, G De Luca, ... Frontiers in immunology 12, 675678, 2021 | 40 | 2021 |
| Intrathecal rituximab for IgG4-related hypertrophic pachymeningitis E Della-Torre, C Campochiaro, EB Cassione, L Albano, S Gerevini, ... Journal of Neurology, Neurosurgery & Psychiatry 89 (4), 441-444, 2018 | 37 | 2018 |
